STOCK TITAN

ZimVie to Report First Quarter 2023 Financial Results on May 3, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

ZimVie Inc. (Nasdaq: ZIMV) will release its first quarter 2023 financial results on May 3, 2023, after market close. A conference call is scheduled for the same day at 4:30 p.m. Eastern Time to discuss the results. Interested participants can register in advance to listen to the call, and an archived replay will be available afterwards on the company’s investor relations website. Founded as a spin-off from Zimmer Biomet in March 2022, ZimVie specializes in the dental and spine markets, providing a range of innovative products aimed at treating spine pathologies and aiding dental procedures. With operations in over 70 countries, ZimVie aims to leverage extensive clinical evidence to support its diversified product portfolio.

Positive
  • Company's upcoming earnings report could signal potential growth in dental and spine markets.
  • ZimVie serves customers in over 70 countries, indicating a broad market presence.
Negative
  • None.

WESTMINSTER, Colo., April 12, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, announced it will report financial results for the first quarter 2023 after market close on Wednesday, May 3, 2023. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.

Those interested in listening to the conference call should register online here. Participants are encouraged to register more than 15 minutes before the start of the call. A replay of the webcast will be available at https://investor.zimvie.com/.

About ZimVie

ZimVie is a global life sciences leader in the dental and spine markets that develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to treat a wide range of spine pathologies and support dental tooth replacement and restoration procedures. In March 2022 the company became an independent, publicly traded spin-off of the dental and spine business units of Zimmer Biomet to breathe new life, dedicated energy, and strategic focus to its portfolio of trusted brands and products. From its headquarters in Westminster, Colorado, and additional facilities around the globe, the company serves customers in over 70 countries worldwide with a robust offering of dental and spine solutions including differentiated product platforms supported by extensive clinical evidence. For more information about ZimVie, please visit us at www.ZimVie.com. Follow @ZimVie on Twitter, Facebook, LinkedIn, or Instagram.

Media Contact Information:

ZimVie
Laura Driscoll • Laura.Driscoll@ZimVie.com
(774) 284-1606

Investor Contact Information:

Gilmartin Group LLC
Marissa Bych • Marissa@Gilmartinir.com


FAQ

When will ZimVie report its first quarter 2023 earnings?

ZimVie will report its first quarter 2023 earnings after market close on May 3, 2023.

What time is the ZimVie conference call scheduled?

The ZimVie conference call is scheduled for 4:30 p.m. Eastern Time on May 3, 2023.

Where can I listen to the ZimVie earnings call?

You can listen to the ZimVie earnings call by registering online through the link provided in their announcement.

What does ZimVie specialize in?

ZimVie specializes in products for the dental and spine markets, focusing on treating spine pathologies and dental restoration.

How many countries does ZimVie operate in?

ZimVie operates in over 70 countries worldwide.

ZimVie Inc.

NASDAQ:ZIMV

ZIMV Rankings

ZIMV Latest News

ZIMV Stock Data

375.90M
27.07M
1.93%
92.3%
1.18%
Medical Devices
Dental Equipment & Supplies
Link
United States of America
PALM BEACH GARDEN